Skip to content
Home›Awards›Novartis Pharmaceuticals Corporation
$

Federal Contract Award

Novartis Pharmaceuticals Corporation

Department of Defense · June 18, 2026 · FY2026

HT941026FE065Full & OpenNAICS 325412

Obligated

$167,285

Contract details

Award ID
CONT_AWD_HT941026FE065_9700_HT941026AE002_9700
PIID
HT941026FE065
Period of performance
June 3, 2026 → September 30, 2026
Place of performance
EAST HANOVER, NJ, USA
Set-aside
None (Full & Open)
Pricing type
FIRM FIXED PRICE
PSC
6505 — DRUGS AND BIOLOGICALS
NAICS
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING

Scope

PLUVICTO AND LUTATHERA INJECTIONS

Parent vehicle (IDV)

Novartis Sanierungsstiftung

UEI YE3YG1FDWMC5

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Novartis Pharmaceuticals Corporation →
UEI
NG61ZA8TADW3
CAGE
04520
Parent
Novartis Sanierungsstiftung
Address
EAST HANOVER, NJ

Awarding agency

Department of Defense →
Sub-agency
Defense Health Agency
Office
DEFENSE HEALTH AGENCY HCD WEST
Funding agency
Department of Defense
Funding office
NAV MED CTR SAN DIEGO CA - MM

See every contract Novartis Pharmaceuticals Corporation has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Novartis Pharmaceuticals Corporation profile →